From Wikipedia, the free encyclopedia
Methoxy arachidonyl fluorophosphonate
|
Names
|
IUPAC name
methyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-
tetraenylphosphonofluoridate
|
Other names
MAFP
|
Identifiers
|
|
|
ChEMBL
|
|
ChemSpider
|
|
|
|
InChI=1S/C21H36FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16- YKey: KWKZCGMJGHHOKJ-ZKWNWVNESA-N YInChI=1/C21H36FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16- Key: KWKZCGMJGHHOKJ-ZKWNWVNEBX
|
FP(=O)(OC)CCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC
|
Properties
|
|
C21H36FO2P
|
Molar mass
|
370.5
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Methoxy arachidonyl fluorophosphonate, commonly referred as MAFP, is an irreversible active site-directed enzyme inhibitor that inhibits nearly all serine hydrolases and serine proteases.[1] It inhibits phospholipase A2 and fatty acid amide hydrolase with special potency, displaying IC50 values in the low-nanomolar range. In addition, it binds to the CB1 receptor in rat brain membrane preparations (IC50 = 20 nM),[2] but does not appear to agonize or antagonize the receptor.[3]
See also
- DIFP - diisopropyl fluorophosphate, a related inhibitor
- IDFP - isopropyl dodecylfluorophosphonate, another related inhibitor with selectivity for FAAH and MAGL
- Activity based probes
References
- ^ Hoover HS, Blankman JL, Niessen S, Cravatt BF (July 2008). "Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling". Bioorg. Med. Chem. Lett. 18 (22): 5838–41. doi:10.1016/j.bmcl.2008.06.091. PMC 2634297. PMID 18657971.
- ^ Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A (1997). "Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase". Biochem. Pharmacol. 53 (3): 255–60. doi:10.1016/s0006-2952(96)00830-1. PMID 9065728.
- ^ Savinainen JR, Saario SM, Niemi R, Järvinen T, Laitinen JT (2003). "An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors". Br. J. Pharmacol. 140 (8): 1451–9. doi:10.1038/sj.bjp.0705577. PMC 1574161. PMID 14623770.
|
---|
Receptor (ligands) | DP (D2)Tooltip Prostaglandin D2 receptor | DP1Tooltip Prostaglandin D2 receptor 1 | |
---|
DP2Tooltip Prostaglandin D2 receptor 2 | |
---|
|
---|
EP (E2)Tooltip Prostaglandin E2 receptor | EP1Tooltip Prostaglandin EP1 receptor | |
---|
EP2Tooltip Prostaglandin EP2 receptor | |
---|
EP3Tooltip Prostaglandin EP3 receptor | |
---|
EP4Tooltip Prostaglandin EP4 receptor | |
---|
Unsorted | |
---|
|
---|
FP (F2α)Tooltip Prostaglandin F receptor | |
---|
IP (I2)Tooltip Prostacyclin receptor | |
---|
TP (TXA2)Tooltip Thromboxane receptor | |
---|
Unsorted | |
---|
|
---|
Enzyme (inhibitors) | COX (PTGS) | |
---|
PGD2STooltip Prostaglandin D synthase | |
---|
PGESTooltip Prostaglandin E synthase | |
---|
PGFSTooltip Prostaglandin F synthase | |
---|
PGI2STooltip Prostacyclin synthase | |
---|
TXASTooltip Thromboxane A synthase | |
---|
|
---|
Others | |
---|
|
|
---|
Receptor (ligands) | BLTTooltip Leukotriene B4 receptor | BLT1Tooltip Leukotriene B4 receptor 1 | |
---|
BLT2Tooltip Leukotriene B4 receptor 2 | |
---|
|
---|
CysLTTooltip Cysteinyl leukotriene receptor | CysLT1Tooltip Cysteinyl leukotriene receptor 1 | |
---|
CysLT2Tooltip Cysteinyl leukotriene receptor 2 | |
---|
CysLTETooltip Cysteinyl leukotriene receptor E | |
---|
|
---|
|
---|
Enzyme (inhibitors) | 5-LOXTooltip Arachidonate 5-lipoxygenase | |
---|
12-LOXTooltip Arachidonate 12-lipoxygenase | |
---|
15-LOXTooltip Arachidonate 15-lipoxygenase | |
---|
LTA4HTooltip Leukotriene A4 hydrolase | |
---|
LTB4HTooltip Leukotriene B4 ω-hydroxylase | |
---|
LTC4STooltip Leukotriene C4 synthase | |
---|
LTC4HTooltip Leukotriene C4 hydrolase | |
---|
LTD4Tooltip Leukotriene D4 hydrolase | |
---|
|
---|
Others | |
---|
|
|
---|
Receptor (ligands) | CB1Tooltip Cannabinoid receptor type 1 | Agonists (abridged, full list) | |
---|
Inverse agonists | |
---|
Antagonists | |
---|
|
---|
CB2Tooltip Cannabinoid receptor type 2 | Agonists |
- 2-AG
- 2-AGE (noladin ether)
- 3,3'-Diindolylmethane
- 4-O-Methylhonokiol
- α-Amyrin · β-Amyrin
- A-796,260
- A-834,735
- A-836,339
- AM-1172
- AM-1221
- AM-1235
- AM-1241
- AM-2232
- Anandamide
- AZ-11713908
- Cannabinol
- Caryophyllene
- CB-13
- CBS-0550
- CP 55,940
- GW-405,833 (L-768,242)
- GW-842,166X
- HU-308
- JTE 7-31
- JWH-007
- JWH-015
- JWH-018
- JWH-73
- JWH-133
- L-759,633
- L-759,656
- Lenabasum (anabasum)
- Magnolol
- MDA-19
- Nabitan
- NADA
- Olorinab (APD-371)
- PF-03550096
- S-444,823
- SER-601
- Serinolamide A
- UR-144
- Tedalinab
- THC (dronabinol)
- THCV
- Tetrahydromagnolol
- Virodhamine
|
---|
Antagonists | |
---|
|
---|
NAGly (GPR18) | |
---|
GPR55 | |
---|
GPR119 | |
---|
|
---|
Transporter (modulators) | eCBTsTooltip Endocannabinoid transporter | |
---|
|
---|
Enzyme (modulators) | |
---|
Others |
- Others: 2-PG (directly potentiates activity of 2-AG at CB1 receptor)
- ARN-272 (FAAH-like anandamide transporter inhibitor)
|
---|
|